203 related articles for article (PubMed ID: 9717062)
1. Diabetic dyslipidaemia.
Erkelens DW
Eur Heart J; 1998 Jul; 19 Suppl H():H27-40. PubMed ID: 9717062
[TBL] [Abstract][Full Text] [Related]
2. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
de Vries R; Borggreve SE; Dullaart RP
Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
[TBL] [Abstract][Full Text] [Related]
3. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
[TBL] [Abstract][Full Text] [Related]
4. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
Chapman MJ; Guérin M; Bruckert E
Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
[TBL] [Abstract][Full Text] [Related]
5. Regulation of plasma triglycerides in insulin resistance and diabetes.
Ginsberg HN; Zhang YL; Hernandez-Ono A
Arch Med Res; 2005; 36(3):232-40. PubMed ID: 15925013
[TBL] [Abstract][Full Text] [Related]
6. Taq1B polymorphism of CETP gene on lipid abnormalities in patients with type II diabetes mellitus.
Yilmaz H; Agachan B; Karaali ZE; Isbir T
Int J Mol Med; 2004 Jun; 13(6):889-93. PubMed ID: 15138631
[TBL] [Abstract][Full Text] [Related]
7. [Triglyceride-rich lipoproteins as risk factors for atherosclerosis].
Schwandt P
Klin Wochenschr; 1990; 68 Suppl 22():54-8. PubMed ID: 2087080
[TBL] [Abstract][Full Text] [Related]
8. Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes?
Shepherd J
Atheroscler Suppl; 2005 Sep; 6(3):15-9. PubMed ID: 16046280
[TBL] [Abstract][Full Text] [Related]
9. Influence of lipolysis on chylomicron clearance and HDL cholesterol levels.
Patsch J
Eur Heart J; 1998 Jul; 19 Suppl H():H2-6. PubMed ID: 9717057
[TBL] [Abstract][Full Text] [Related]
10. Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients.
Yoshida H; Hirowatari Y; Kurosawa H; Tada N
Clin Sci (Lond); 2005 Sep; 109(3):297-302. PubMed ID: 15907189
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
[TBL] [Abstract][Full Text] [Related]
12. Very low density lipoproteins in type II diabetes mellitus and risk of atherosclerosis.
Schwandt P
Horm Metab Res Suppl; 1985; 15():80-3. PubMed ID: 3865885
[TBL] [Abstract][Full Text] [Related]
13. [Disorders of lipid metabolism in insulin resistance].
Müller-Wieland D; Krone W
Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475
[TBL] [Abstract][Full Text] [Related]
14. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
[TBL] [Abstract][Full Text] [Related]
15. Enhanced cellular uptake of remnant high-density lipoprotein particles: a mechanism for high-density lipoprotein lowering in insulin resistance and hypertriglyceridemia.
Xiao C; Watanabe T; Zhang Y; Trigatti B; Szeto L; Connelly PW; Marcovina S; Vaisar T; Heinecke JW; Lewis GF
Circ Res; 2008 Jul; 103(2):159-66. PubMed ID: 18556574
[TBL] [Abstract][Full Text] [Related]
16. Lipid modification in type 2 diabetes: the role of LDL and HDL.
Vergès B
Fundam Clin Pharmacol; 2009 Dec; 23(6):681-5. PubMed ID: 19650852
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
[TBL] [Abstract][Full Text] [Related]
18. Streptozotocin-induced increase in cholesterol ester transfer protein (CETP) and its reversal by insulin in transgenic mice expressing human CETP.
Cheema SK; Rashid-Kolvear F
Can J Physiol Pharmacol; 2003 Oct; 81(10):997-1004. PubMed ID: 14608418
[TBL] [Abstract][Full Text] [Related]
19. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
